论文部分内容阅读
目的:本院主要是对尿激酶溶栓治疗心源性脑梗塞的临床进行相关分析。方法:主要针对2010年到2012年到本院进行治疗的56例心源性脑梗塞患者进行相关的分组治疗,随机抽取其中的28例患者,将其分为实验组,应用的治疗方法为常规治疗配合尿激酶溶栓治疗。将剩下的28例患者分为对照组,应用的治疗方法为常规的治疗方法。实验组和对照组的治疗周期为14天,并在治疗的第一天、第三天、第五天、第七天和第十四天分别对相应的功能进行测评,然后对最后的治疗效果进行比较。结果:在为期14天的治疗过程中,实验组的治疗效果明显优于对照组的治疗效果。结论:尿激酶溶栓对于治疗心源性脑梗塞有着良好的治疗效果,值得推广应用。
Objective: The hospital mainly for urokinase thrombolytic therapy of cardio-cerebral infarction clinical correlation analysis. Methods: Fifty-six patients with cardio-cerebral infarction who were treated in our hospital from 2010 to 2012 were divided into related groups. 28 patients were randomly selected and divided into experimental groups. The treatment methods used were routine Treatment with urokinase thrombolytic therapy. The remaining 28 patients were divided into control group, the application of the treatment method for the conventional treatment. The experimental group and control group were treated for 14 days, and the corresponding functions were evaluated on the first day, the third day, the fifth day, the seventh day and the fourteenth day of the treatment respectively, and then the final treatment effect Compare. Results: During the 14-day treatment, the treatment effect of the experimental group was significantly better than that of the control group. Conclusion: Urokinase thrombolytic therapy for the treatment of cardio cerebral infarction has a good therapeutic effect, it is worth promoting the application.